Photon Counting CT and Radiomic Analysis Enables Differentiation of Tumors Based on Lymphocyte Burden.
micro-CT
nanoparticles
photon counting detector
preclinical
radiogenomics
radiomics
spectral CT
Journal
Tomography (Ann Arbor, Mich.)
ISSN: 2379-139X
Titre abrégé: Tomography
Pays: Switzerland
ID NLM: 101671170
Informations de publication
Date de publication:
10 03 2022
10 03 2022
Historique:
received:
17
12
2021
revised:
04
03
2022
accepted:
08
03
2022
entrez:
22
3
2022
pubmed:
23
3
2022
medline:
25
3
2022
Statut:
epublish
Résumé
The purpose of this study was to investigate if radiomic analysis based on spectral micro-CT with nanoparticle contrast-enhancement can differentiate tumors based on lymphocyte burden. High mutational load transplant soft tissue sarcomas were initiated in
Identifiants
pubmed: 35314638
pii: tomography8020061
doi: 10.3390/tomography8020061
pmc: PMC8938796
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
740-753Subventions
Organisme : NIDCR NIH HHS
ID : K08 DE029887
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA220245
Pays : United States
Organisme : NIDCR NIH HHS
ID : U01 DE028233
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG070149
Pays : United States
Références
JCI Insight. 2019 May 21;4(13):
pubmed: 31112524
Phys Med Biol. 2020 Mar 19;65(6):065009
pubmed: 32023555
Adv Anat Pathol. 2017 Nov;24(6):311-335
pubmed: 28777143
Abdom Radiol (NY). 2021 Aug 25;:
pubmed: 34435228
Eur Radiol. 2010 Sep;20(9):2126-34
pubmed: 20309554
J Med Imaging (Bellingham). 2019 Jan;6(1):011004
pubmed: 30840718
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
AJR Am J Roentgenol. 2006 Feb;186(2):300-7
pubmed: 16423931
Proc SPIE Int Soc Opt Eng. 2016 Feb;9783:
pubmed: 27346908
Acad Radiol. 2011 Jan;18(1):20-30
pubmed: 21145026
IEEE Trans Pattern Anal Mach Intell. 2005 Aug;27(8):1226-38
pubmed: 16119262
Acta Derm Venereol. 2020 Nov 18;100(18):adv00323
pubmed: 33135769
Biochem Pharmacol. 2009 Sep 15;78(6):539-52
pubmed: 19413999
Contrast Media Mol Imaging. 2021 Jun 14;2021:6641384
pubmed: 34220380
Adv Radiat Oncol. 2019 May 22;4(4):748-752
pubmed: 31673668
J Control Release. 2000 Mar 1;65(1-2):271-84
pubmed: 10699287
Phys Med Biol. 2019 Mar 12;64(6):065007
pubmed: 30708357
Cytokine Growth Factor Rev. 2010 Feb;21(1):3-10
pubmed: 20005150
Phys Med Biol. 2019 Jan 08;64(2):025007
pubmed: 30524018
Radiol Imaging Cancer. 2021 Apr;3(4):e200157
pubmed: 34114913
Inverse Probl. 2011 Nov 1;27(11):
pubmed: 22223929
J Drugs Dermatol. 2020 Dec 1;19(12):1241-1246
pubmed: 33346505
Theranostics. 2018 Feb 12;8(7):1782-1797
pubmed: 29556356
Br J Radiol. 2017 Feb;90(1070):20160665
pubmed: 27936886
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1369-1373
pubmed: 31968143
Nat Commun. 2020 Dec 17;11(1):6410
pubmed: 33335088
Phys Med Biol. 2016 Feb 21;61(4):1572-95
pubmed: 26835839
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Phys Med Biol. 2018 Nov 08;63(22):225003
pubmed: 30272571
Cell. 1992 Mar 6;68(5):855-67
pubmed: 1547487
Med Phys. 2011 Dec;38(12):6754-62
pubmed: 22149857
Adv Enzyme Regul. 2001;41:189-207
pubmed: 11384745
PLoS One. 2012;7(4):e34496
pubmed: 22485175
PLoS One. 2019 Sep 19;14(9):e0218417
pubmed: 31536493
Med Phys. 2021 Jul;48(7):3767-3777
pubmed: 33959972
PLoS One. 2017 Jul 6;12(7):e0180324
pubmed: 28683124
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1353-9
pubmed: 23122984
Clin Cancer Res. 2021 Apr 1;27(7):1958-1966
pubmed: 33495310